Most preventative interventions in medicine are single-system tools — a statin works on LDL, a metformin on glucose, an SGLT2 on the kidney. Tadalafil is unusual because the mechanism — selective inhibition of PDE5 with downstream enhancement of nitric oxide signaling — sits underneath the function of every blood vessel in the body. That single point of leverage produces benefits across cardiovascular, cognitive, urinary, erectile, and exercise endpoints. The Limitless protocol adds 5 mg PO daily to the standard adult-male recommendation, barring contraindications, on this basis.
The mechanism in one paragraph.
Endothelial cells line the inside of every blood vessel. They produce nitric oxide (NO), a signaling molecule that diffuses into smooth muscle, raises cyclic GMP, and triggers vasodilation. As we age, endothelial NO signaling deteriorates — both because NO production drops and because cyclic GMP is broken down faster by phosphodiesterase enzymes. Tadalafil inhibits PDE5, the dominant phosphodiesterase in vascular smooth muscle, prolonging the action of whatever NO signal is being produced. The half-life is long (~17.5 hours), making once-daily dosing trivially feasible, and the receptor selectivity is good enough that off-target effects are minimal at the 5 mg dose.
1. Cardiovascular — the oldest indication.
PDE5 inhibition has documented effects on systemic vascular resistance, pulmonary arterial pressure, and endothelial-dependent vasodilation. The signal is most established in pulmonary arterial hypertension (where tadalafil is FDA-approved at higher doses), but at 5 mg daily the effect on systemic endothelial function is the relevant outcome — modest, real, and additive with the rest of a cardiovascular optimization program.
2. Cognitive — the provocative indication.
Cerebral blood flow declines with age in patterns that track with executive function decline. PDE5 inhibition improves cerebrovascular reactivity in human studies, and observational data suggest a possible reduced incidence of Alzheimer's disease in long-term PDE5 inhibitor users. The data is not yet randomized-trial confirmed for prevention, but the mechanistic plausibility is strong and the safety profile is well-characterized — which is why the cognitive angle is increasingly cited by Stanford's Dr. Mike Eisenberg and others as a reason to consider daily dosing earlier in life.
3. Urinary — the FDA-approved indication.
Tadalafil is FDA-approved at 5 mg daily for benign prostatic hyperplasia (BPH) symptoms. The mechanism is improved smooth-muscle relaxation in the prostate and bladder neck. Patients on the daily protocol commonly report better urinary stream and reduced nocturia within a few weeks, even when BPH was not the primary reason for prescribing.
4. Erectile — the obvious indication.
Tadalafil is FDA-approved for erectile dysfunction, and the daily dosing schedule produces near-continuous PDE5 inhibition rather than the on-demand response of single doses. For most men, the practical outcome is restored spontaneity rather than scheduled performance. We do not lead with this in our patient conversations — the longevity case is more important — but it is a real benefit and worth disclosing honestly.
5. Exercise — the secondary indication.
Endothelial-dependent vasodilation in skeletal muscle improves oxygen delivery during exertion. The trial data here is smaller and more variable, but the signal is consistent enough that endurance athletes use tadalafil at altitude, where pulmonary vasodilation is the relevant adaptation.
How we prescribe it.
Standing protocol for adult-male Limitless patients without a contraindication: tadalafil 5 mg PO once daily. Reduce to 2.5 mg in severe renal impairment, mild hepatic impairment, age 70+ at first prescription, concurrent strong CYP3A4 inhibitor, concurrent alpha-blocker, or low baseline blood pressure. Absolute contraindications: concurrent organic nitrates, severe hypotension, recent acute coronary syndrome (within 90 days), severe hepatic impairment, hereditary degenerative retinal disorders, and history of NAION. The full protocol page lives at /protocols/tadalafil-daily.